
Privacy notice | Accessibility statement | Terms and conditions | Login | Contact |
UK data driving real-world evidence
Bibliography
Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 6 April 2021) and papers are listed below and in the PDF below.
If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.
Download:
(PDF, 5MB, 226 pages)This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website.
“Pregnancy losses in women with Type 1 or Type 2 diabetes in the UK: an investigation using primary care records”, Diabet Med, vol. 31, pp. 357-65, 2014.
, “Asthma management in pregnancy”, PLoS One, vol. 8, p. e60247, 2013.
, “Colorectal cancer risk reduction following macrogol exposure: a cohort and nested case control study in the UK”, PLoS One, vol. 8, p. e83203, 2013.
, “Pandemic influenza vaccination during pregnancy: an investigation of vaccine uptake during the 2009/10 pandemic vaccination campaign in Great Britain”, Hum Vaccin Immunother, vol. 9, pp. 917-23, 2013.
, ,
,
,
“Data resources for investigating drug exposure during pregnancy and associated outcomes: the General Practice Research Database (GPRD) as an alternative to pregnancy registries”, Drug Saf, vol. 31, pp. 39-51, 2008.
, “Endometriosis and its coexistence with irritable bowel syndrome and pelvic inflammatory disease: findings from a national case-control study–Part 2”, Bjog, vol. 115, pp. 1392-6, 2008.
, “Risk of myocardial infarction in men and women with type 2 diabetes in the UK: a cohort study using the General Practice Research Database”, Diabetologia, vol. 51, pp. 1639-45, 2008.
, “Systemic lupus erythematosus prevalence in the UK: methodological issues when using the General Practice Research Database to estimate frequency of chronic relapsing-remitting disease”, Pharmacoepidemiol Drug Saf, vol. 16, pp. 144-51, 2007.
, “Venous thromboembolism and cyproterone acetate in men with prostate cancer: a study using the General Practice Research Database”, BJU Int, vol. 99, pp. 1398-403, 2007.
, “Incidence of clinically diagnosed systemic lupus erythematosus 1992-1998 using the UK General Practice Research Database”, Pharmacoepidemiol Drug Saf, vol. 15, pp. 656-61, 2006.
, “Myocardial infarction risk and hormone replacement: differences between products”, Maturitas, vol. 53, pp. 343-50, 2006.
, “Tibolone and endometrial cancer: a cohort and nested case-control study in the UK”, Drug Saf, vol. 28, pp. 241-9, 2005.
, “A drug utilisation study of antidepressants in children and adolescents using the General Practice Research Database”, Arch Dis Child, vol. 89, pp. 1098-102, 2004.
, “Utilisation of hormone replacement therapy in the United Kingdom. A descriptive study using the general practice research database”, Bjog, vol. 111, pp. 369-76, 2004.
, “Venous thromboembolism associated with cyproterone acetate in combination with ethinyloestradiol (Dianette): observational studies using the UK General Practice Research Database”, Pharmacoepidemiol Drug Saf, vol. 13, pp. 427-36, 2004.
, “Differences in the use of combined oral contraceptives amongst women with and without acne”, Hum Reprod, vol. 18, pp. 515-21, 2003.
, “The risk of liver disorders in women prescribed cyproterone acetate in combination with ethinyloestradiol (Dianette): a nested case-control study using the GPRD”, Pharmacoepidemiol Drug Saf, vol. 12, pp. 541-50, 2003.
, ,